Intuitive Surgical Key Executives
This section highlights Intuitive Surgical's key executives, including their titles and compensation details.
Find Contacts at Intuitive Surgical
( total contacts)
Intuitive Surgical Earnings
This section highlights Intuitive Surgical's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
April 17, 2025
Time:
Before Market
Est. EPS:
$1.71
Status:
Unconfirmed
Last Earnings Results
Date:
January 23, 2025
EPS:
$2.21
Est. EPS:
$1.76
Revenue:
$2.41B
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-01-23 | $1.76 | $2.21 |
| Read Transcript | Q3 | 2024 | 2024-10-17 | $1.63 | $1.84 |
| Read Transcript | Q2 | 2024 | 2024-07-18 | $1.54 | $1.78 |
| Read Transcript | Q1 | 2024 | 2024-04-18 | $1.41 | $1.50 |
| Read Transcript | Q4 | 2023 | 2024-01-23 | $1.48 | $1.60 |
| Read Transcript | Q3 | 2023 | 2023-10-19 | $1.41 | $1.46 |
| Read Transcript | Q2 | 2023 | 2023-07-20 | $1.33 | $1.42 |
| Read Transcript | Q1 | 2023 | 2023-04-18 | $1.20 | $1.23 |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Healthcare
Medical - Instruments & Supplies
$492.06
Stock Price
$175.50B
Market Cap
15.64K
Employees
Sunnyvale, CA
Location
Financial Statements
Access annual & quarterly financial statements for Intuitive Surgical, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $8.35B | $7.12B | $6.22B | $5.71B | $4.36B |
| Cost of Revenue | $2.72B | $2.39B | $2.03B | $1.75B | $1.50B |
| Gross Profit | $5.63B | $4.73B | $4.20B | $3.96B | $2.86B |
| Gross Profit Ratio | 67.50% | 66.40% | 67.44% | 69.30% | 65.65% |
| Research and Development Expenses | $1.15B | $998.80M | $879.00M | $671.00M | $595.10M |
| General and Administrative Expenses | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $2.14B | $1.96B | $1.74B | $1.47B | $1.22B |
| Other Expenses | $- | $- | $- | $- | $- |
| Operating Expenses | $3.29B | $2.96B | $2.62B | $2.14B | $1.81B |
| Cost and Expenses | $-6.00B | $5.36B | $4.65B | $3.89B | $3.31B |
| Interest Income | $324.90M | $192.10M | $29.70M | $69.30M | $157.20M |
| Interest Expense | $- | $- | $29.70M | $- | $- |
| Depreciation and Amortization | $324.90M | $421.80M | $380.40M | $317.00M | $282.50M |
| EBITDA | $2.67B | $2.17B | $1.94B | $2.13B | $1.33B |
| EBITDA Ratio | 32.01% | 30.45% | 25.35% | 31.89% | 24.09% |
| Operating Income | $2.35B | $1.77B | $1.21B | $1.82B | $773.60M |
| Operating Income Ratio | 28.12% | 24.80% | 19.47% | 31.89% | 17.75% |
| Total Other Income Expenses Net | $324.90M | $192.10M | $29.70M | $69.30M | $157.20M |
| Income Before Tax | $2.67B | $1.96B | $1.61B | $1.89B | $1.21B |
| Income Before Tax Ratio | 32.01% | 27.50% | 25.82% | 33.10% | 27.69% |
| Income Tax Expense | $336.30M | $141.60M | $262.40M | $162.20M | $140.20M |
| Net Income | $2.32B | $1.80B | $1.32B | $1.70B | $1.06B |
| Net Income Ratio | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% |
| EPS | $6.54 | $5.12 | $3.72 | $4.79 | $3.02 |
| EPS Diluted | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 |
| Weighted Average Shares Outstanding | 355.20M | 351.20M | 355.70M | 356.10M | 351.00M |
| Weighted Average Shares Outstanding Diluted | 362.00M | 357.40M | 362.00M | 365.80M | 360.90M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.41B | $2.04B | $2.01B | $1.89B | $1.93B | $1.74B | $1.76B | $1.70B | $1.66B | $1.56B | $1.52B | $1.49B | $1.55B | $1.40B | $1.46B | $1.29B | $1.33B | $1.08B | $852.10M | $1.10B |
| Cost of Revenue | $771.30M | $664.20M | $637.20M | $645.20M | $650.90M | $576.50M | $584.00M | $583.20M | $544.10M | $505.30M | $498.80M | $478.00M | $489.90M | $431.90M | $440.30M | $389.50M | $433.30M | $353.40M | $349.20M | $361.30M |
| Gross Profit | $1.64B | $1.37B | $1.37B | $1.25B | $1.28B | $1.17B | $1.17B | $1.11B | $1.11B | $1.05B | $1.02B | $1.01B | $1.06B | $971.40M | $1.02B | $902.60M | $895.80M | $724.30M | $502.90M | $738.20M |
| Gross Profit Ratio | 68.00% | 67.40% | 68.30% | 65.90% | 66.20% | 66.90% | 66.70% | 65.60% | 67.10% | 67.60% | 67.20% | 67.90% | 68.40% | 69.20% | 69.90% | 69.90% | 67.40% | 67.21% | 59.02% | 67.14% |
| Research and Development Expenses | $294.70M | $286.00M | $280.10M | $284.50M | $260.10M | $249.40M | $244.40M | $244.90M | $244.10M | $217.10M | $207.30M | $210.50M | $183.40M | $165.50M | $162.30M | $159.80M | $149.80M | $155.00M | $143.20M | $147.10M |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $308.10M | $- | $- | $308.10M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $22.10M | $- | $- | $- |
| Selling General and Administrative Expenses | $612.60M | $510.60M | $525.30M | $491.50M | $567.10M | $452.00M | $464.30M | $480.50M | $494.30M | $436.10M | $418.40M | $391.10M | $427.00M | $363.30M | $350.20M | $326.00M | $330.20M | $298.90M | $279.10M | $308.10M |
| Other Expenses | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Operating Expenses | $907.30M | $796.60M | $805.40M | $776.00M | $827.20M | $701.40M | $708.70M | $725.40M | $738.40M | $653.20M | $625.70M | $601.60M | $610.40M | $528.80M | $512.50M | $485.80M | $480.00M | $453.90M | $422.30M | $455.20M |
| Cost and Expenses | $-1.68B | $1.46B | $1.44B | $1.42B | $1.48B | $1.28B | $1.29B | $1.31B | $1.28B | $1.16B | $1.12B | $1.08B | $1.10B | $960.70M | $952.80M | $875.30M | $913.30M | $807.30M | $771.50M | $816.50M |
| Interest Income | $74.90M | $- | $87.20M | $- | $92.50M | $45.80M | $36.00M | $37.90M | $22.20M | $3.90M | $9.30M | $- | $- | $- | $- | $32.00M | $20.70M | $- | $- | $- |
| Interest Expense | $- | $- | $- | $- | $28.70M | $- | $- | $- | $22.20M | $3.90M | $9.30M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $74.90M | $116.20M | $111.80M | $109.30M | $114.00M | $108.60M | $97.30M | $92.70M | $112.10M | $89.80M | $86.00M | $83.80M | $83.20M | $82.10M | $78.90M | $71.70M | $79.80M | $69.20M | $63.80M | $63.40M |
| EBITDA | $809.80M | $693.50M | $679.10M | $578.70M | $553.80M | $574.40M | $560.50M | $480.30M | $506.80M | $488.70M | $483.60M | $491.90M | $528.50M | $524.60M | $586.80M | $488.50M | $490.20M | $339.60M | $144.40M | $346.40M |
| EBITDA Ratio | 33.55% | 34.03% | 33.79% | 30.61% | 29.74% | 32.94% | 26.38% | 22.85% | 22.51% | 25.61% | 26.12% | 27.43% | 29.04% | 31.54% | 34.92% | 32.26% | 31.28% | 25.09% | 9.46% | 25.74% |
| Operating Income | $734.90M | $577.30M | $567.30M | $469.40M | $450.20M | $465.80M | $365.90M | $294.90M | $266.30M | $309.10M | $311.60M | $324.30M | $450.40M | $442.60M | $511.20M | $416.80M | $415.80M | $270.40M | $80.60M | $283.00M |
| Operating Income Ratio | 30.45% | 28.33% | 28.23% | 24.83% | 23.35% | 26.71% | 20.84% | 17.39% | 16.09% | 19.85% | 20.47% | 21.80% | 29.04% | 31.54% | 34.92% | 32.26% | 31.28% | 25.09% | 9.46% | 25.74% |
| Total Other Income Expenses Net | $74.90M | $93.70M | $87.20M | $69.10M | $65.70M | $56.20M | $36.00M | $34.20M | $22.20M | $3.90M | $9.30M | $-5.70M | $3.80M | $18.50M | $15.00M | $32.00M | $20.70M | $84.80M | $26.60M | $25.10M |
| Income Before Tax | $809.80M | $671.00M | $654.50M | $538.50M | $515.90M | $522.00M | $499.20M | $421.80M | $394.70M | $402.80M | $406.90M | $402.40M | $454.20M | $461.10M | $526.20M | $448.80M | $436.50M | $355.20M | $107.20M | $308.10M |
| Income Before Tax Ratio | 33.55% | 32.92% | 32.56% | 28.48% | 26.75% | 29.94% | 28.43% | 24.87% | 23.85% | 25.86% | 26.73% | 27.05% | 29.29% | 32.86% | 35.94% | 34.73% | 32.84% | 32.96% | 12.58% | 28.02% |
| Income Tax Expense | $121.80M | $100.40M | $123.00M | $-8.90M | $-94.80M | $102.20M | $73.20M | $61.00M | $58.00M | $78.10M | $93.30M | $33.00M | $71.50M | $73.90M | $3.20M | $13.60M | $72.90M | $38.40M | $37.00M | $-8.10M |
| Net Income | $685.70M | $565.10M | $526.90M | $544.90M | $606.20M | $415.70M | $420.80M | $355.30M | $324.90M | $324.00M | $307.80M | $365.60M | $380.60M | $380.50M | $517.20M | $426.30M | $365.20M | $313.90M | $68.00M | $313.50M |
| Net Income Ratio | 28.41% | 27.73% | 26.22% | 28.82% | 31.44% | 23.84% | 23.96% | 20.95% | 19.63% | 20.80% | 20.22% | 24.57% | 24.54% | 27.11% | 35.33% | 32.99% | 27.48% | 29.13% | 7.98% | 28.51% |
| EPS | $1.92 | $1.59 | $1.48 | $1.54 | $1.72 | $1.18 | $1.20 | $1.01 | $0.93 | $0.91 | $0.86 | $1.02 | $1.06 | $1.07 | $1.45 | $3.61 | $1.04 | $0.89 | $0.19 | $0.90 |
| EPS Diluted | $1.88 | $1.56 | $1.46 | $1.51 | $1.69 | $1.16 | $1.18 | $1.00 | $0.91 | $0.90 | $0.85 | $1.00 | $1.04 | $1.04 | $1.42 | $3.51 | $1.01 | $0.87 | $0.19 | $0.87 |
| Weighted Average Shares Outstanding | 356.40M | 355.80M | 355.00M | 353.50M | 352.10M | 351.70M | 350.90M | 350.20M | 351.10M | 355.30M | 358.10M | 358.40M | 357.50M | 356.80M | 355.80M | 353.40M | 352.80M | 351.90M | 350.40M | 349.20M |
| Weighted Average Shares Outstanding Diluted | 363.90M | 362.70M | 361.00M | 360.50M | 358.20M | 358.20M | 357.30M | 356.00M | 357.00M | 360.50M | 363.90M | 366.70M | 367.40M | 366.80M | 364.80M | 362.85M | 363.30M | 361.80M | 359.10M | 359.40M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $2.03B | $2.75B | $1.58B | $1.29B | $1.62B |
| Short Term Investments | $1.99B | $2.47B | $2.54B | $2.94B | $3.55B |
| Cash and Short Term Investments | $4.01B | $5.22B | $6.74B | $8.62B | $6.87B |
| Net Receivables | $1.36B | $1.27B | $1.07B | $893.00M | $645.50M |
| Inventory | $1.49B | $1.22B | $893.20M | $587.10M | $601.50M |
| Other Current Assets | $253.70M | $176.70M | $168.60M | $133.90M | $393.80M |
| Total Current Assets | $7.11B | $7.89B | $8.58B | $9.99B | $8.12B |
| Property Plant Equipment Net | $4.65B | $3.54B | $2.37B | $1.88B | $1.58B |
| Goodwill | $347.50M | $348.70M | $348.50M | $343.60M | $336.70M |
| Intangible Assets | $23.00M | $39.10M | $49.80M | $70.50M | $77.40M |
| Goodwill and Intangible Assets | $370.50M | $387.80M | $348.50M | $343.60M | $336.70M |
| Long Term Investments | $4.82B | $2.12B | $2.62B | $4.42B | $1.76B |
| Tax Assets | $1.05B | $910.50M | $664.60M | $441.40M | $367.70M |
| Other Non-Current Assets | $750.90M | $597.60M | $-1.61B | $-3.51B | $-986.60M |
| Total Non-Current Assets | $11.63B | $7.55B | $4.40B | $3.57B | $3.05B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
| Account Payables | $193.40M | $188.70M | $147.00M | $121.20M | $81.60M |
| Short Term Debt | $- | $- | $- | $20.40M | $- |
| Tax Payables | $154.40M | $111.40M | $96.10M | $54.10M | $47.20M |
| Deferred Revenue | $468.80M | $446.10M | $438.30M | $414.00M | $382.40M |
| Other Current Liabilities | $928.70M | $912.50M | $781.70M | $576.90M | $486.10M |
| Total Current Liabilities | $1.75B | $1.66B | $1.86B | $1.60B | $1.41B |
| Long Term Debt | $- | $64.50M | $69.60M | $66.60M | $58.00M |
| Deferred Revenue Non-Current | $- | $45.60M | $41.00M | $36.80M | $32.10M |
| Deferred Tax Liabilities Non-Current | $- | $- | $-69.60M | $- | $81.00M |
| Other Non-Current Liabilities | $468.30M | $275.40M | $328.70M | $350.30M | $354.50M |
| Total Non-Current Liabilities | $468.30M | $385.50M | $439.30M | $224.10M | $139.00M |
| Other Liabilities | $- | $1 | $-439.30M | $-224.10M | $-139.00M |
| Total Liabilities | $2.21B | $2.04B | $1.86B | $1.60B | $1.41B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $400.00K | $400.00K | $400.00K | $400.00K | $100.00K |
| Retained Earnings | $6.80B | $4.74B | $3.50B | $4.76B | $3.26B |
| Accumulated Other Comprehensive Income Loss | $-51.30M | $-12.20M | $-162.50M | $-24.20M | $24.90M |
| Other Total Stockholders Equity | $9.68B | $8.58B | $7.70B | $7.16B | $6.45B |
| Total Stockholders Equity | $16.43B | $13.31B | $11.11B | $11.95B | $9.76B |
| Total Equity | $16.53B | $13.40B | $11.18B | $12.00B | $9.79B |
| Total Liabilities and Stockholders Equity | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
| Minority Interest | $95.90M | $89.70M | $70.70M | $50.40M | $27.60M |
| Total Liabilities and Total Equity | $18.74B | $15.44B | $12.97B | $13.55B | $11.17B |
| Total Investments | $6.80B | $4.59B | $5.16B | $7.36B | $5.31B |
| Total Debt | $- | $89.80M | $93.80M | $87.00M | $79.90M |
| Net Debt | $-2.03B | $-2.66B | $-1.49B | $-1.20B | $-1.54B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $2.03B | $2.41B | $3.04B | $2.84B | $2.75B | $3.60B | $3.44B | $371.40M | $1.58B | $1.54B | $1.54B | $1.10B | $1.29B | $1.35B | $1.62B | $1.40B | $1.62B | $1.37B | $2.04B | $1.22B |
| Short Term Investments | $1.99B | $1.82B | $1.72B | $1.96B | $2.47B | $2.87B | $2.36B | $2.55B | $2.54B | $2.78B | $2.91B | $2.89B | $2.94B | $2.79B | $2.82B | $3.16B | $3.55B | $3.35B | $2.45B | $2.03B |
| Cash and Short Term Investments | $4.01B | $4.23B | $4.76B | $4.80B | $5.22B | $6.48B | $7.13B | $6.58B | $6.74B | $7.39B | $8.18B | $8.40B | $8.62B | $8.22B | $7.73B | $7.23B | $6.87B | $6.36B | $6.07B | $5.90B |
| Net Receivables | $1.36B | $1.29B | $1.24B | $1.26B | $1.27B | $1.10B | $1.04B | $1.06B | $1.07B | $971.10M | $955.00M | $1.02B | $893.00M | $793.60M | $794.30M | $733.30M | $645.50M | $588.60M | $508.80M | $527.60M |
| Inventory | $1.49B | $1.48B | $1.38B | $1.30B | $1.22B | $1.15B | $1.01B | $946.60M | $893.20M | $837.10M | $724.00M | $653.00M | $587.10M | $584.90M | $569.70M | $576.80M | $601.50M | $662.90M | $645.50M | $620.30M |
| Other Current Assets | $253.70M | $212.20M | $270.00M | $272.90M | $176.70M | $- | $188.60M | $- | $168.60M | $165.90M | $167.50M | $138.60M | $133.90M | $217.50M | $213.40M | $198.80M | $267.50M | $330.60M | $258.80M | $502.00M |
| Total Current Assets | $7.11B | $7.22B | $7.65B | $7.63B | $7.89B | $8.90B | $9.04B | $8.45B | $8.58B | $9.08B | $9.74B | $9.96B | $9.99B | $9.50B | $9.00B | $8.46B | $8.12B | $7.61B | $7.59B | $7.41B |
| Property Plant Equipment Net | $4.65B | $4.43B | $4.12B | $3.80B | $3.54B | $3.08B | $2.83B | $2.58B | $2.37B | $2.24B | $2.11B | $1.97B | $1.88B | $1.74B | $1.65B | $1.59B | $1.58B | $1.51B | $1.45B | $1.37B |
| Goodwill | $347.50M | $348.30M | $348.00M | $348.20M | $348.70M | $348.10M | $348.60M | $348.60M | $348.50M | $348.20M | $349.10M | $343.20M | $343.60M | $344.30M | $344.30M | $344.50M | $336.70M | $336.30M | $336.80M | $335.00M |
| Intangible Assets | $23.00M | $25.30M | $28.70M | $33.80M | $636.70M | $638.40M | $693.10M | $5.00M | $49.80M | $57.10M | $66.20M | $64.10M | $70.50M | $77.20M | $84.00M | $87.20M | $77.40M | $88.90M | $101.00M | $488.00M |
| Goodwill and Intangible Assets | $370.50M | $373.60M | $376.70M | $382.00M | $985.40M | $986.50M | $348.60M | $348.60M | $348.50M | $348.20M | $349.10M | $343.20M | $343.60M | $344.30M | $344.30M | $344.50M | $336.70M | $336.30M | $336.80M | $335.00M |
| Long Term Investments | $4.82B | $4.08B | $3.14B | $2.73B | $2.12B | $1.04B | $1.33B | $1.89B | $2.62B | $3.08B | $3.74B | $4.42B | $4.42B | $4.13B | $3.30B | $2.67B | $1.76B | $1.64B | $1.59B | $2.64B |
| Tax Assets | $1.05B | $997.00M | $946.90M | $917.80M | $910.50M | $701.40M | $666.50M | $644.70M | $664.60M | $587.40M | $515.90M | $485.40M | $441.40M | $411.50M | $394.40M | $336.60M | $367.70M | $360.30M | $365.50M | $364.70M |
| Other Non-Current Assets | $750.90M | $644.40M | $412.40M | $364.00M | $- | $- | $-316.20M | $-857.20M | $-1.61B | $-2.08B | $-2.75B | $-3.50B | $-3.51B | $-3.19B | $-2.39B | $-1.87B | $-986.60M | $-844.90M | $-1.23B | $-2.23B |
| Total Non-Current Assets | $11.63B | $10.53B | $9.00B | $8.20B | $7.55B | $5.81B | $4.86B | $4.60B | $4.40B | $4.18B | $3.97B | $3.72B | $3.57B | $3.44B | $3.29B | $3.08B | $3.05B | $3.00B | $2.51B | $2.48B |
| Other Assets | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B | $14.71B | $13.90B | $13.05B | $12.97B | $13.26B | $13.71B | $13.68B | $13.55B | $12.93B | $12.30B | $11.54B | $11.17B | $10.62B | $10.10B | $9.89B |
| Account Payables | $193.40M | $218.70M | $194.40M | $194.40M | $188.70M | $196.20M | $199.70M | $164.10M | $147.00M | $164.20M | $149.70M | $128.10M | $121.20M | $120.00M | $117.90M | $103.10M | $81.60M | $116.00M | $108.90M | $133.40M |
| Short Term Debt | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $20.40M | $- | $- | $- | $- | $- | $- | $- |
| Tax Payables | $154.40M | $164.60M | $85.90M | $51.80M | $111.40M | $342.80M | $230.20M | $125.40M | $96.10M | $71.20M | $40.80M | $113.30M | $54.10M | $65.90M | $58.80M | $50.70M | $47.20M | $35.30M | $37.70M | $34.60M |
| Deferred Revenue | $468.80M | $426.00M | $433.90M | $437.50M | $446.10M | $394.80M | $450.60M | $462.50M | $438.30M | $395.60M | $413.70M | $424.40M | $414.00M | $383.50M | $392.00M | $389.20M | $382.40M | $358.10M | $371.50M | $366.20M |
| Other Current Liabilities | $928.70M | $867.50M | $773.30M | $691.40M | $912.50M | $742.60M | $703.30M | $600.10M | $781.70M | $639.10M | $608.20M | $484.80M | $576.90M | $492.90M | $467.90M | $392.70M | $486.10M | $415.60M | $435.10M | $440.50M |
| Total Current Liabilities | $1.75B | $1.68B | $1.49B | $1.38B | $1.66B | $1.68B | $1.94B | $1.76B | $1.86B | $1.69B | $1.62B | $1.52B | $1.60B | $1.48B | $1.42B | $1.35B | $1.41B | $1.33B | $1.34B | $1.36B |
| Long Term Debt | $- | $- | $- | $- | $64.50M | $- | $- | $- | $69.60M | $- | $- | $- | $66.60M | $- | $- | $- | $58.00M | $- | $- | $- |
| Deferred Revenue Non-Current | $54.10M | $59.60M | $43.50M | $50.20M | $45.60M | $42.50M | $45.40M | $44.70M | $41.00M | $36.70M | $37.40M | $38.40M | $36.80M | $35.00M | $32.00M | $31.10M | $32.10M | $30.30M | $28.40M | $28.80M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $82.10M | $- | $- | $- | $-69.60M | $- | $- | $- | $229.60M | $- | $- | $- | $-58.00M | $- | $- | $- |
| Other Non-Current Liabilities | $414.20M | $329.50M | $322.40M | $356.30M | $275.40M | $370.30M | $359.80M | $406.90M | $328.70M | $416.70M | $410.40M | $370.90M | $350.30M | $412.80M | $380.90M | $414.50M | $354.50M | $405.80M | $384.00M | $385.90M |
| Total Non-Current Liabilities | $468.30M | $389.10M | $365.90M | $406.50M | $385.50M | $412.80M | $405.20M | $462.50M | $439.30M | $453.40M | $447.80M | $409.30M | $453.70M | $447.80M | $412.90M | $445.60M | $444.60M | $436.10M | $412.40M | $414.70M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $-405.20M | $-462.50M | $-439.30M | $-453.40M | $-447.80M | $-409.30M | $-453.70M | $-447.80M | $-412.90M | $-445.60M | $-444.60M | $-436.10M | $-412.40M | $-414.70M |
| Total Liabilities | $2.21B | $2.07B | $1.85B | $1.78B | $2.04B | $2.09B | $1.94B | $1.76B | $1.86B | $1.69B | $1.62B | $1.52B | $1.60B | $1.48B | $1.42B | $1.35B | $1.41B | $1.33B | $1.34B | $1.36B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $80.60M | $- | $- | $- | $- | $- | $50.40M | $48.60M | $42.00M | $36.70M | $27.60M | $28.90M | $25.90M | $23.80M |
| Common Stock | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K |
| Retained Earnings | $6.80B | $6.13B | $5.58B | $5.07B | $4.74B | $4.21B | $3.81B | $3.40B | $3.50B | $4.02B | $4.68B | $4.86B | $4.76B | $4.39B | $4.02B | $3.51B | $3.26B | $2.94B | $2.63B | $2.57B |
| Accumulated Other Comprehensive Income Loss | $-51.30M | $12.90M | $-23.50M | $-8.70M | $-12.20M | $-56.50M | $-79.80M | $-108.50M | $-162.50M | $-187.60M | $-144.20M | $-110.70M | $-24.20M | $5.30M | $10.30M | $11.40M | $24.90M | $16.20M | $22.30M | $8.90M |
| Other Total Stockholders Equity | $9.68B | $9.44B | $9.15B | $8.90B | $8.58B | $8.39B | $8.15B | $7.93B | $7.70B | $7.68B | $7.48B | $7.35B | $7.16B | $7.02B | $6.80B | $6.63B | $6.45B | $6.30B | $6.09B | $5.93B |
| Total Stockholders Equity | $16.43B | $15.58B | $14.71B | $13.96B | $13.31B | $12.54B | $11.96B | $11.29B | $11.11B | $11.57B | $12.08B | $12.16B | $11.95B | $11.46B | $10.88B | $10.19B | $9.76B | $9.29B | $8.77B | $8.53B |
| Total Equity | $16.53B | $15.68B | $14.80B | $14.05B | $13.40B | $12.62B | $12.04B | $11.37B | $11.18B | $11.63B | $12.14B | $12.21B | $12.00B | $11.51B | $10.92B | $10.23B | $9.79B | $9.32B | $8.79B | $8.55B |
| Total Liabilities and Stockholders Equity | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B | $14.71B | $13.90B | $13.05B | $12.97B | $13.26B | $13.71B | $13.68B | $13.55B | $12.93B | $12.30B | $11.54B | $11.17B | $10.62B | $10.10B | $9.89B |
| Minority Interest | $95.90M | $94.20M | $88.20M | $83.80M | $89.70M | $84.50M | $80.60M | $76.50M | $70.70M | $58.60M | $59.40M | $54.60M | $50.40M | $48.60M | $42.00M | $36.70M | $27.60M | $28.90M | $25.90M | $23.80M |
| Total Liabilities and Total Equity | $18.74B | $17.74B | $16.65B | $15.83B | $15.44B | $14.71B | $13.90B | $13.05B | $12.97B | $13.26B | $13.71B | $13.68B | $13.55B | $12.93B | $12.30B | $11.54B | $11.17B | $10.62B | $10.10B | $9.89B |
| Total Investments | $6.80B | $5.90B | $4.86B | $4.69B | $4.59B | $3.92B | $3.70B | $4.44B | $5.16B | $5.86B | $6.65B | $7.31B | $7.36B | $6.92B | $6.12B | $5.83B | $5.31B | $4.99B | $4.04B | $4.67B |
| Total Debt | $- | $- | $- | $- | $89.80M | $- | $- | $- | $93.80M | $- | $- | $- | $87.00M | $- | $- | $- | $58.00M | $275.70M | $- | $- |
| Net Debt | $-2.03B | $-2.41B | $-3.04B | $-2.84B | $-2.66B | $-3.60B | $-3.44B | $-371.40M | $-1.49B | $-1.54B | $-1.54B | $-1.10B | $-1.20B | $-1.35B | $-1.62B | $-1.40B | $-1.56B | $-1.09B | $-2.04B | $-1.22B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $2.34B | $1.82B | $1.34B | $1.73B | $1.07B |
| Depreciation and Amortization | $462.00M | $435.20M | $365.80M | $310.20M | $276.20M |
| Deferred Income Tax | $-135.30M | $-280.80M | $-185.30M | $-62.60M | $57.60M |
| Stock Based Compensation | $676.80M | $598.20M | $513.20M | $449.20M | $395.40M |
| Change in Working Capital | $-919.30M | $-777.60M | $-619.10M | $-368.10M | $-273.20M |
| Accounts Receivables | $-95.90M | $-186.30M | $-159.30M | $-142.30M | $5.70M |
| Inventory | $-830.00M | $-712.50M | $-546.60M | $-256.00M | $-170.10M |
| Accounts Payables | $-400.00K | $41.70M | $21.30M | $36.00M | $-32.30M |
| Other Working Capital | $7.00M | $79.50M | $65.50M | $-5.80M | $-76.50M |
| Other Non Cash Items | $-6.70M | $21.50M | $71.80M | $32.60M | $-38.00M |
| Net Cash Provided by Operating Activities | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B |
| Investments in Property Plant and Equipment | $-1.11B | $-1.06B | $-532.40M | $-353.50M | $-341.50M |
| Acquisitions Net | $-1.00M | $-8.90M | $-12.80M | $-8.70M | $-37.70M |
| Purchases of Investments | $-5.14B | $-2.21B | $-1.40B | $-6.45B | $-4.29B |
| Sales Maturities of Investments | $2.98B | $2.92B | $3.32B | $4.35B | $3.73B |
| Other Investing Activities | $- | $- | $1.92B | $-2.10B | $-561.40M |
| Net Cash Used for Investing Activities | $-3.27B | $-360.10M | $1.37B | $-2.46B | $-940.60M |
| Debt Repayment | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $233.80M | $276.50M | $308.80M |
| Common Stock Repurchased | $- | $-416.30M | $-2.61B | $-211.60M | $-134.30M |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $150.90M | $128.70M | $35.10M | $43.00M | $48.60M |
| Net Cash Used Provided by Financing Activities | $150.90M | $-287.60M | $-2.57B | $43.00M | $-85.70M |
| Effect of Forex Changes on Cash | $-800.00K | $3.30M | $5.40M | $-3.40M | $-2.60M |
| Net Change in Cash | $-707.70M | $1.17B | $294.70M | $-332.50M | $455.90M |
| Cash at End of Period | $2.06B | $2.77B | $1.60B | $1.31B | $1.64B |
| Cash at Beginning of Period | $2.77B | $1.60B | $1.31B | $1.64B | $1.18B |
| Operating Cash Flow | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B |
| Capital Expenditure | $-1.11B | $-1.06B | $-532.40M | $-353.50M | $-341.50M |
| Free Cash Flow | $1.30B | $749.60M | $958.40M | $1.74B | $1.14B |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $688.00M | $570.60M | $531.50M | $547.40M | $610.70M | $419.80M | $426.00M | $360.80M | $336.70M | $324.70M | $313.60M | $369.40M | $382.70M | $387.20M | $523.00M | $435.20M | $363.60M | $316.80M | $70.20M | $316.20M |
| Depreciation and Amortization | $124.70M | $116.20M | $111.80M | $109.30M | $123.20M | $108.60M | $97.30M | $92.70M | $106.20M | $89.80M | $86.00M | $83.80M | $80.90M | $82.00M | $75.60M | $71.70M | $79.80M | $69.20M | $63.80M | $63.40M |
| Deferred Income Tax | $-30.80M | $-64.70M | $-32.60M | $-7.20M | $-219.80M | $-43.30M | $-27.00M | $9.30M | $-83.30M | $-61.90M | $-25.70M | $-14.40M | $-22.00M | $-16.60M | $-68.70M | $44.70M | $-14.30M | $19.40M | $-12.00M | $64.50M |
| Stock Based Compensation | $177.00M | $172.90M | $173.60M | $153.30M | $150.40M | $156.10M | $146.50M | $139.80M | $127.60M | $138.10M | $126.70M | $120.80M | $117.80M | $120.10M | $108.10M | $103.20M | $103.10M | $105.80M | $95.90M | $90.60M |
| Change in Working Capital | $-140.80M | $-85.60M | $-152.90M | $-540.00M | $-439.20M | $-100.80M | $5.90M | $-243.50M | $-60.80M | $-124.20M | $-68.70M | $-365.40M | $-10.90M | $-79.00M | $-108.70M | $-169.50M | $81.50M | $-179.00M | $10.50M | $-186.20M |
| Accounts Receivables | $-74.10M | $-42.80M | $18.80M | $2.20M | $-166.60M | $-59.00M | $22.40M | $16.90M | $-92.10M | $-11.20M | $67.40M | $-123.40M | $-87.60M | $4.90M | $-45.30M | $-14.30M | $-51.50M | $-79.70M | $18.70M | $118.20M |
| Inventory | $-179.10M | $-261.50M | $-209.80M | $-179.60M | $-184.30M | $-239.60M | $-161.50M | $-127.10M | $-127.50M | $-173.60M | $-125.40M | $-120.10M | $-66.80M | $-96.80M | $-51.20M | $-41.20M | $6.90M | $-56.90M | $-54.90M | $-65.20M |
| Accounts Payables | $-21.60M | $22.80M | $5.90M | $-7.50M | $14.00M | $-8.80M | $19.60M | $16.90M | $-5.00M | $13.90M | $14.30M | $-1.90M | $200.00K | $-2.40M | $14.50M | $23.70M | $-28.40M | $-300.00K | $-25.50M | $21.90M |
| Other Working Capital | $134.00M | $195.90M | $32.20M | $-355.10M | $-102.30M | $206.60M | $125.40M | $-150.20M | $163.80M | $46.70M | $-25.00M | $-120.00M | $143.30M | $15.30M | $-26.70M | $-137.70M | $154.50M | $-42.10M | $72.20M | $-261.10M |
| Other Non Cash Items | $4.50M | $-2.90M | $-10.90M | $2.60M | $3.00M | $8.00M | $17.00M | $12.30M | $11.50M | $16.70M | $14.80M | $28.80M | $19.20M | $7.70M | $13.40M | $-7.70M | $13.80M | $-57.60M | $1.50M | $4.30M |
| Net Cash Provided by Operating Activities | $822.60M | $706.50M | $620.50M | $265.40M | $228.30M | $548.40M | $665.70M | $371.40M | $437.90M | $383.20M | $446.70M | $223.00M | $567.70M | $501.40M | $542.70M | $477.60M | $627.50M | $274.60M | $229.90M | $352.80M |
| Investments in Property Plant and Equipment | $-312.00M | $-247.90M | $-309.40M | $-241.90M | $-435.50M | $-256.30M | $-178.30M | $-194.10M | $-137.70M | $-169.10M | $-130.50M | $-95.10M | $-150.90M | $-68.30M | $-75.70M | $-58.60M | $-61.90M | $-64.40M | $-110.00M | $-105.20M |
| Acquisitions Net | $-1.00M | $- | $- | $- | $-1.80M | $200.00K | $-7.30M | $-767.20M | $-1.20M | $200.00K | $-11.80M | $-1.50M | $-14.00M | $- | $- | $-8.70M | $-105.20M | $- | $- | $-37.70M |
| Purchases of Investments | $-1.43B | $-1.92B | $-883.50M | $-905.90M | $-1.39B | $-806.20M | $-10.50M | $-3.50M | $-5.90M | $-17.40M | $-188.90M | $-1.19B | $-1.24B | $-1.71B | $-1.67B | $-1.83B | $-1.27B | $-1.60B | $-736.80M | $-690.00M |
| Sales Maturities of Investments | $478.80M | $755.10M | $725.80M | $1.02B | $780.30M | $615.70M | $753.70M | $770.70M | $719.60M | $730.80M | $797.40M | $1.07B | $748.20M | $935.50M | $1.37B | $1.30B | $997.30M | $634.90M | $1.38B | $715.80M |
| Other Investing Activities | $- | $- | $- | $- | $-606.90M | $-190.50M | $743.20M | $767.20M | $713.70M | $713.40M | $608.50M | $-119.60M | $-490.10M | $-770.50M | $-309.00M | $-529.70M | $105.20M | $-961.50M | $646.70M | $25.80M |
| Net Cash Used for Investing Activities | $-1.26B | $-1.41B | $-467.10M | $-128.50M | $-1.04B | $-446.60M | $557.60M | $573.10M | $574.80M | $544.50M | $466.20M | $-214.70M | $-641.00M | $-838.80M | $-384.70M | $-597.00M | $-334.30M | $-1.03B | $536.70M | $-117.10M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $- | $- | $44.10M | $77.40M | $74.60M | $100.20M | $- | $- | $- | $80.00M | $276.50M | $91.10M | $69.70M | $84.00M | $- | $- | $- | $91.30M |
| Common Stock Repurchased | $- | $- | $- | $- | $-66.30M | $-14.80M | $-10.90M | $-350.00M | $-1.00B | $-1.00B | $-500.10M | $-106.50M | $-10.40M | $-13.30M | $-9.60M | $- | $-34.30M | $-10.20M | $-6.20M | $-100.00M |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $49.40M | $98.20M | $50.00M | $-46.70M | $78.90M | $61.80M | $63.30M | $-31.20M | $82.50M | $155.20M | $18.00M | $-93.40M | $18.60M | $68.30M | $58.30M | $-186.20M | $35.40M | $85.20M | $47.60M | $-78.70M |
| Net Cash Used Provided by Financing Activities | $49.40M | $98.20M | $50.00M | $-46.70M | $-31.50M | $61.80M | $63.30M | $-381.20M | $-963.50M | $-926.80M | $-482.10M | $-199.90M | $18.60M | $68.30M | $58.30M | $-102.20M | $-39.80M | $85.20M | $47.60M | $-178.70M |
| Effect of Forex Changes on Cash | $8.30M | $-12.20M | $-3.70M | $6.80M | $-5.40M | $1.70M | $5.20M | $1.80M | $-2.50M | $1.90M | $2.20M | $3.80M | $-1.10M | $300.00K | $-3.40M | $800.00K | $-600.00K | $-400.00K | $-800.00K | $-800.00K |
| Net Change in Cash | $-383.90M | $-620.50M | $199.70M | $97.00M | $-852.80M | $165.30M | $1.29B | $565.10M | $46.70M | $2.80M | $433.00M | $-187.80M | $-55.80M | $-268.80M | $212.90M | $-220.80M | $252.80M | $-666.50M | $813.40M | $56.20M |
| Cash at End of Period | $2.06B | $2.45B | $3.07B | $2.87B | $2.77B | $3.62B | $3.46B | $2.17B | $1.60B | $1.55B | $1.55B | $1.12B | $1.31B | $1.36B | $1.63B | $1.42B | $1.64B | $1.39B | $2.05B | $1.24B |
| Cash at Beginning of Period | $2.45B | $3.07B | $2.87B | $2.77B | $3.62B | $3.46B | $2.17B | $1.60B | $1.55B | $1.55B | $1.12B | $1.31B | $1.36B | $1.63B | $1.42B | $1.64B | $1.39B | $2.05B | $1.24B | $1.18B |
| Operating Cash Flow | $822.60M | $706.50M | $620.50M | $265.40M | $228.30M | $548.40M | $665.70M | $371.40M | $437.90M | $383.20M | $446.70M | $223.00M | $567.70M | $501.40M | $542.70M | $477.60M | $627.50M | $274.60M | $229.90M | $352.80M |
| Capital Expenditure | $-312.00M | $-247.90M | $-309.40M | $-241.90M | $-435.50M | $-256.30M | $-178.30M | $-194.10M | $-137.70M | $-169.10M | $-130.50M | $-95.10M | $-150.90M | $-68.30M | $-75.70M | $-58.60M | $-61.90M | $-64.40M | $-110.00M | $-105.20M |
| Free Cash Flow | $510.60M | $458.60M | $311.10M | $23.50M | $-207.20M | $292.10M | $487.40M | $177.30M | $300.20M | $214.10M | $316.20M | $127.90M | $416.80M | $433.10M | $467.00M | $419.00M | $565.60M | $210.20M | $119.90M | $247.60M |
Intuitive Surgical Dividends
Explore Intuitive Surgical's dividend history, including dividend yield, payout ratio, and historical payments.
Intuitive Surgical News
Read the latest news about Intuitive Surgical, including recent articles, headlines, and updates.
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
ISRG Stock Price Falls to 200-DMA: Should You Buy, Hold or Sell?
Shares of Intuitive Surgical ISRG have declined 16.5% in the past month, with the price currently trading around its 200-day moving average (200-DMA). The price corrected after touching its all-time high of $616 in January, followed by a retest of the psychological level of $600 in February.
Intuitive Surgical: Leading The Next-Generation Surgery Market
I am bullish on Intuitive Surgical, Inc. due to da Vinci 5's advanced capabilities, reducing surgery complications and blood transfusions significantly compared to open surgeries. Intuitive Surgical's da Vinci 5 offers enhanced range of motion, realistic 3D imaging, and reduced operative time, improving surgical outcomes and patient comfort. Despite being overvalued, ISRG's technological advancements and high investor expectations position it well for growth in the minimally invasive surgery market.
2 Top Growth Stocks to Buy Hand Over Fist in the Nasdaq Correction
The Nasdaq has been a surefire winner over the past two years, soaring in the double digits annually. Investors were optimistic about the potential for a lower interest rate environment ahead and the fact that such a backdrop could benefit high-growth companies.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Intuitive Surgical is Known for Selling $1 Million Surgical Robots. But Here's How it Actually Makes Most of its Revenue.
Intuitive Surgical (ISRG 1.26%)best known for its flagship da Vinci robot, is the global leader in the robotic surgery market. The da Vinci, available in several versions including the latest da Vinci 5, generates billions of dollars of revenue annually, and this performance has helped the company's stock soar over the near term and the long term.
The Ultimate Healthcare Robotics Stock to Buy With $600 Right Now
Robotics is something that is transforming many industries -- and one of the biggest winners is the area of healthcare. Using robots in minimally invasive surgeries has been shown to decrease chances of complications, shorten hospital stays, and lower mortality rates.
If You'd Invested $10,000 in Intuitive Surgical Stock 10 Years Ago, Here's How Much You'd Have Today
Many of us occasionally look at an impressive stock that we don't own and wonder, "How much would I have today if I'd invested in it some years ago?" One company that those in the know might wonder about is Intuitive Surgical (ISRG -0.15%) -- a giant in the robotic surgery arena.
Intuitive Surgical Just Posted a Solid Quarter, but This Is Why the Stock Could Be in Trouble This Year
Intuitive Surgical (ISRG 1.94%) should arguably be doing a whole lot better after coming off the release of some strong earnings numbers. Business is doing well, the growth rate is solid, and in the long run, the company has a lot of potential.
Is Intuitive Surgical Stock a Buy?
Intuitive Surgical (ISRG 1.30%) capped off a record-breaking 2024 with a blowout fourth-quarter earnings report. For the period ended Dec. 31, the medical technologies (medtech) giant delivered adjusted earnings per share (EPS) of $2.21, well above the $1.79 consensus Wall Street estimate.
Buy, Sell, Or Hold ISRG Stock At $585?
Intuitive Surgical (NASDAQ: ISRG) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $2.4 billion and adjusted earnings of $2.21 per share, compared to the consensus estimates of $2.2 billion and $1.79, respectively.
Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education
SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced a $45 million gift to the Intuitive Foundation that will be used to support the Foundation's mission of reducing the global burden of disease and suffering through philanthropy, research, and education aimed at better outcomes for patients everywhere.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for ISRG.
Financial Analysis
Company Intelligence
Income & Revenue
Returns & Ratios
Balance Sheet
Dividends
...
...